This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Combined contraceptive pill and antibiotics

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In 2011 BNF advice changed in line with expert opinion to advise that combined hormonal contraception (CHC) users are not required to use additional contraception when taking non-enzyme-inducing antibiotics.

Women should be advised about the importance of correct contraceptive practice during periods of illness

  • according to recent evidence, most broad-spectrum antibiotics are non-enzyme-inducing and do not require any special precautions. No additional contraceptive precaution is required unless the antibiotics (and/or illness) cause vomiting or diarrhoea

If using an enzyme-inducing antibiotic e.g. rifabutin, rifampicin - then will need to use additional contraceptive precautions and for four weeks after stopping the antibiotic.

Notes:

  • use of antibiotics in treatment of acne whilst on combined hormonal contraception:
    • the FSRH guidance means that there is no indication for additional contraception when starting prolonged antibacterial therapy (as may occur in management of acne) unless the antibiotic is an enzyme-inducing antibiotic

Reference:

  1. FSRH (2019), Clinical Guidance: Drug Interactions with Hormonal Contraception.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.